Nalaganje...
Unplanned discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia
This study was conducted to investigate the outcomes of patients with chronic myeloid leukemia (CML) who discontinued tyrosine kinase inhibitor (TKI) treatment. A single-center retrospective analysis was performed, including 46 chronic-phase (CP) CML patients who achieved complete molecular response...
Shranjeno v:
| izdano v: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4727029/ https://ncbi.nlm.nih.gov/pubmed/26870364 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.653 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|